Tisotumab vedotin-tftv (Tivdak®) Management

This PQI in Action is a follow up to the Tisotumab vedotin-tftv (Tivdak®) Management PQI and explores how the medically integrated teams at Mitchell Cancer Institute and Johns Hopkins collaborate and utilize the information found in the PQI as part of their daily practice. This article will discuss how utilizing the Tisotumab vedotin-tftv (Tivdak®) Management PQI elevates patient care.